| |
| |
|
| Insider
Information: |
Simonian Nancy A |
| Relationship: |
|
| City: |
Woburn |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
131,658 |
|
|
Indirect Shares
|
164,975 |
|
|
| Direct
Value |
$705,687 |
|
|
|
Indirect Value
|
$857,600 |
|
|
| Total
Shares |
296,633 |
|
|
| Total
Value |
$1,563,287 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Millennium Pharmaceuticals Inc |
MLNM |
Chief Medical Officer |
2008-05-14 |
0 |
2008-05-01 |
4,975 |
Premium* |
|
|
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2013-05-17 |
0 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
|
2024-04-01 |
131,658 |
2016-07-06 |
160,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MLNM |
Millennium Pharmaceutical... |
Chief Medical OfficerOfficer |
• – – |
2007-05-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
69,012 |
|
- |
|
| MLNM |
Millennium Pharmaceutical... |
Chief Medical OfficerOfficer |
• – – |
2007-05-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,424 |
|
- |
|
| MLNM |
Millennium Pharmaceutical... |
Chief Medical Officer |
• – – |
2007-12-13 |
4 |
OE |
$6.88 |
$895,355 |
D/D |
110,834 |
179,899 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
Chief Medical Officer |
• – – |
2007-12-13 |
4 |
S |
$15.41 |
$1,745,770 |
D/D |
(113,063) |
66,836 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
Chief Medical Officer |
• – – |
2008-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
30,940 |
97,776 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
Chief Medical Officer |
• – – |
2008-02-29 |
4 |
AS |
$13.68 |
$25,299 |
D/D |
(1,850) |
95,926 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
Chief Medical Officer |
• – – |
2008-03-03 |
4 |
AS |
$13.99 |
$44,069 |
D/D |
(3,150) |
92,776 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
Chief Medical Officer |
• – – |
2008-03-05 |
4 |
AS |
$13.55 |
$78,764 |
D/D |
(5,813) |
86,963 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
Chief Medical Officer |
• – – |
2008-03-06 |
4 |
AS |
$13.25 |
$155,409 |
D/D |
(11,729) |
75,234 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
Chief Medical Officer |
• – – |
2008-05-01 |
4 |
AS |
$24.88 |
$53,069 |
D/D |
(2,133) |
77,410 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
Chief Medical Officer |
• – – |
2008-05-14 |
4 |
D |
$25.00 |
$1,935,250 |
D/D |
(77,410) |
0 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2013-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
3,500 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2014-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
7,000 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2015-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
10,700 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2016-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
14,400 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President & CEOOfficer |
• • • |
2016-06-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
304,036 |
|
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President & CEOOfficer |
• • • |
2016-06-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
160,000 |
|
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President and CEO |
• • – |
2016-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
66,666 |
370,702 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2017-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
18,100 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2018-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
21,800 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President & CEO |
• • – |
2018-11-29 |
4 |
OE |
$1.01 |
$136,224 |
D/D |
110,588 |
481,288 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President & CEO |
• • – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
188,000 |
669,288 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2019-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,963 |
24,763 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President & CEO |
• • – |
2019-12-23 |
4 |
OE |
$3.04 |
$159,299 |
D/D |
52,401 |
533,689 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2020-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,335 |
26,098 |
0 |
- |
|
37 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
